Oncology Venture ApS - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

Oncology Venture ApS (Oncology Venture), a subsidiary of Oncology Venture Sweden AB, is a developer of oncology products. The company offers products in the therapeutic areas of metastatic breast cancer, ovarian cancer, renal cancer, liver cancer, prostate cancer, multiple myeloma, and others. It provides gene-tumor-technology for identifying patients with resistance to anticancer drug. Oncology Ventures activities include in-licensing drugs with low response rate performing phase II trials on a selected population and identifying the ones that are positive for its proprietary biomarker; and out-licensing the drugs with high response rate. It conducts research and development to discover new drugs. The company partners with other pharmaceutical companies to co-develop oncology drugs. Oncology Venture is headquartered in Hoersholm, Denmark.

Oncology Venture ApS - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

it derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.



List of Tables 4
List of Figures 4
Oncology Venture ApS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Oncology Venture ApS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Oncology Venture ApS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Oncology Venture ApS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Oncology Venture ApS, Medical Devices Deals, 2012 to YTD 2018 9
Oncology Venture ApS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Oncology Venture ApS, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Oncology Venture Acquires Drug Response Predictor from Medical Prognosis Institute 11
Venture Financing 12
Oncology Venture Raises USD0.56 Million in Venture Financing 12
Merger 13
Oncology Venture to Merger with Medical Prognosis Institute 13
Licensing Agreements 14
Oncology Venture Exercises Option to In-License Dovitinib with Novartis Pharma 14
Oncology Venture Enters into Licensing Agreement with Lantern Pharma 15
Oncology Venture Enters into Licensing Agreement with Medical Prognosis Institute 16
TopoTarget Enters Into Licensing Agreement With Oncology Venture For APO010 17
Equity Offering 18
Oncology Venture Raises USD1 Million in Private Placement of Shares 18
Oncology Venture ApS - Key Competitors 19
Oncology Venture ApS - Key Employees 20
Oncology Venture ApS - Locations And Subsidiaries 21
Head Office 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List Of Tables


Oncology Venture ApS, Pharmaceuticals & Healthcare, Key Facts 2
Oncology Venture ApS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Oncology Venture ApS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Oncology Venture ApS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Oncology Venture ApS, Deals By Therapy Area, 2012 to YTD 2018 8
Oncology Venture ApS, Medical Devices Deals, 2012 to YTD 2018 9
Oncology Venture ApS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Oncology Venture Acquires Drug Response Predictor from Medical Prognosis Institute 11
Oncology Venture Raises USD0.56 Million in Venture Financing 12
Oncology Venture to Merger with Medical Prognosis Institute 13
Oncology Venture Exercises Option to In-License Dovitinib with Novartis Pharma 14
Oncology Venture Enters into Licensing Agreement with Lantern Pharma 15
Oncology Venture Enters into Licensing Agreement with Medical Prognosis Institute 16
TopoTarget Enters Into Licensing Agreement With Oncology Venture For APO010 17
Oncology Venture Raises USD1 Million in Private Placement of Shares 18
Oncology Venture ApS, Key Competitors 19
Oncology Venture ApS, Key Employees 20

List Of Figures


Oncology Venture ApS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Oncology Venture ApS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Oncology Venture ApS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Oncology Venture ApS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Oncology Venture ApS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Oncology Venture ApS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Oncology Venture ApS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Oncology Venture ApS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Oncology Venture ApS, Medical Devices Deals, 2012 to YTD 2018 9

Cardiff Oncology Inc (CRDF) - Financial and Strategic SWOT Analysis Review

Cardiff Oncology Inc (CRDF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled to

USD 125 View Report

AVEO Oncology Inc (AVEO) - Financial and Strategic SWOT Analysis Review

AVEO Oncology Inc (AVEO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled to

USD 125 View Report

Oncology Venture ApS - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Oncology Venture ApS (Oncology Venture), a subsidiary of Oncology Venture Sweden AB, is a developer of oncology products. The company offers products in the therapeutic areas of metastatic breast cancer,

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available